White House bypassed FDA to distribute ineffective COVID-19 Rx to pharmacies
November 3, 2020
Internal White House documents obtained as a result of a Freedom of Information Act request show that the Trump administration went around the Food and Drug Administration and established safety controls to distribute hydroxychloroquine to pharmacies around the U.S. The Trump administration, led by trade advisor Peter Navarro, pushed the distribution, although there was no scientific evidence to support its use as a COVID-19 treatment and there was evidence the drug could be harmful to some patients, particularly those with coronary issues. The White House ordered the distribution of 23 million hydroxychloroquine tablets taken from the Strategic National Stockpile to a dozen states.
Recent News
Spotify Faces Disruptions After Layoffs
During Spotify’s recent earnings call, CEO Daniel Ek acknowledged that the company’s decision to lay off employees last December had a more substantial impact on operations than initially anticipated.
Clear’s Airport Line-Skipping Faces California Scrutiny
Clear, a biometric scanning service, lets travelers skip airport security lines for $189 a year. Now, California lawmakers are pushing back against its expansion.
Walgreens Broadens Specialty Pharmacy Services for Cell and Gene Therapies
Walgreens revealed its plans to collaborate directly with drug manufacturers to provide cell and gene therapies to patients in the U.S.
Meta’s Threads Has 150 Million Monthly Active Users According to Mark Zuckerberg
Meta’s Threads, which entered the market to compete with the likes of X, is growing at a robust rate.